The targeted integration of scientific and engineering competencies at the new interdisciplinary research center will make innovative methods and technologies in the fields of artificial intelligence (AI) and data science available for use in various medical fields.
Under the umbrella of the Munich Data Science Institute (MDSI), the ZDMG will operate as a standalone research center, developing new data-driven approaches and methodologies and promoting their use to benefit patients, in particular in treatments of cancer and cardiovascular disease and in neurological medicine.
A primary focus will be the development of individualized and personalized treatments and interventions. In that regard, the early detection and diagnosis of diseases and the identification of biomarkers and treatment objectives using AI and data science will play a crucial role. Another focus will be on security and privacy protection when using patient data and the ethically responsible application of the new data-driven technologies.
For the interactive visualization of big data in medicine, plans for the ZDMG also include a data observatory. With this unique facility – the largest of its kind in Europe – it will be possible to visualize very large datasets from clinical laboratory results, image data and more complex data such as genetic mutations and cellular changes and compare them on multiple screens. This may help to discover previously unknown patterns and correlations that may point the way forward to new therapeutic options.
"The ZDMG offers a unique opportunity to pool the strengths of the university hospital Klinikum rechts der Isar and the Technical University of Munich and to advance digital healthcare through data-driven approaches," says Prof. Daniel Rückert, the future head of the center.
Digital medicine is a key area under the research and excellence strategy of TUM, embodied in various consortia, research institutes and collaborations. "The ZDMG will bundle the TUM-wide digital medicine activities. The new building will play a vital role in the development of the key area of digital health and technology within the framework of the future TUM School of Medicine & Health," says Prof. Bernhard Hemmer, the Dean of the School of Medicine.
Stressing the importance of the ZDMG, Dr. Martin Siess, Medical Director and CEO of TUM’s university hospital Klinikum rechts der Isar, says: "The new building for the digital medicine center on the university hospital Klinikum rechts der Isar campus also represents a milestone for our patients because the ability of scientists to collaborate with doctors is crucial for the translation of research into modern patient care."
MEDICA-tradefair.com; Source: Technical University of Munich
